In a small trial across ten U.S. research sites, a novel HIV vaccine candidate has shown a result that has eluded scientists ...

We may be a step closer to a highly effective mRNA vaccine against HIV, but tests so far reveal that the approach can cause ...

Medical advancements are a wonderful thing. When HIV was first discovered back in the 1980s, it was considered a death ...

Evidence is growing that some HIV-infected infants, if given antiretroviral drugs early in life, are able to suppress their ...

HIV anti-retroviral therapy is considered a treatment and not a cure because patients usually carry a reservoir of HIV-infected cells that can re-emerge if treatment stops. These reservoirs have ...

Though these pieces of viral RNA and protein were non-functional "debris," the researchers found that they were enough to stimulate an immune response. Since stronger HIV-specific immune responses ...

The in vitro experiments found that introducing the Nef protein to immune cells resulted in the expression of pro-inflammatory genes that remain switched on, even when the HIV protein was no ...

Scientists have determined the molecular structure of HIV Pol, a protein that plays a key role in the late stages of HIV replication, or the process through which the virus propagates itself and ...

A cell-free antigen processing system informs HIV-1 epitope selection and vaccine design. Journal of Experimental Medicine, 2023; 220 (7) DOI: 10.1084/jem.20221654 ...

Using something called an HIV-like particle (HLP)—which are dead HIV particles containing HIV proteins that trigger an immune response in a patient—may help treat the disease, scientists from ...

Women living with HIV represent 23% of people affected in Canada and form the second fastest-growing group, after Indigenous people. However, women are systematically underrepresented in HIV trials.

The human immunodeficiency virus (HIV) chiefly targets CD4 cells. A low number of these cells and a low ratio (under 1.0) of CD4 and CD8 cells are signs of HIV infection.